HELIOS Kliniken

Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response (2022) Loibl S, Schneeweiss A, Huober J, Braun M, Rey J, Blohmer JU, Furlanetto J, et al. Journal article Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS) (2022) Bielack SS, Blattmann C, Borkhardt A, Csóka M, Hassenpflug W, Kabíčková E, Kager L, et al. Journal article Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study (2022) Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, et al. Journal article, Letter Ticagrelor or Prasugrel in Patients with Acute Coronary Syndrome and High Bleeding Risk (2022) Lahu S, Presch A, Ndrepepa G, Menichelli M, Valina C, Hemetsberger R, Witzenbichler B, et al. Journal article Anti-SARS-CoV-2 vaccination immune response in MS patients: interim results of a multicentre, prospective cohort study (2022) Berthele A, Goedel C, Kallmann B, Kowarik M, Lehmann-Horn K, Marziniak M, Meyer C, et al. Conference contribution S2k Leitlinie: Diagnostik und Therapie des chronischen Pruritus (2022) Ständer S, Zeidler C, Augustin M, Darsow U, Kremer A, Legat FJ, Koschmieder S, et al. Journal article S2k guideline: Diagnosis and treatment of chronic pruritus (2022) Ständer S, Zeidler C, Augustin M, Darsow U, Kremer A, Legat FJ, Koschmieder S, et al. Journal article Advanced Breast Cancer: AGO Recommendations 2022 – Focus on ABC6 Consensus (2022) Untch M, Fasching P, Haidinger R, Harbeck N, Jackisch C, Lüftner D, Müller V, et al. Journal article, Review article AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022 (2022) Banys-Paluchowski M, Thill M, Kuhn T, Ditsch N, Heil J, Woeckel A, Fallenberg E, et al. Journal article Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes-a subgroup analysis of the ISAR-REACT 5 trial (2022) Lahu S, Ndrepepa G, Neumann FJ, Menichelli M, Bernlochner I, Richardt G, Wohrle J, et al. Journal article